In the 1970s, there was widespread doubt in Britain over the safety of the DTP vaccine
for diphtheria, tetanus and pertussis (whooping cough).
The DTP vaccine
would provide shield to the children against diphtheria, pertussis and tetanus.
The DTP vaccine
is a shield against diphtheria, pertussis and tetanus.
Since the introduction of DTP vaccine
in 1981, the overall incidence of pertussis dropped dramatically by late eighties.
In these three regions in 2016, 11 million infants did not receive their first dose of DTP vaccine
, and 18 million did not receive their first dose of MCV.
Until the 1990s, the DTP vaccine
, which includes a whole pertussis bacterium, was highly effective at preventing pertussis but could cause febrile seizures, an adverse event that proved too intolerable for many families.
(4) Prior to this, the suggestion in the 1970s that the DTP vaccine
was related to infant brain damage resulted in vaccination rates for the DTP vaccine
dropping to 30% in Britain, (5) a situation that led to three major outbreaks of whooping cough over a 12-year period, 300,000 notifications and over 70 deaths.
(118) Indeed, in 1985 alone, plaintiffs filed a total of 100 lawsuits against just one manufacturer, Lederle Laboratories, claiming injury following the administration of its DTP vaccine
, which eclipsed the number of lawsuits filed against Lederle in the previous three years combined.
While measles, BCG, and smallpox vaccines have beneficial nonspecific effects, DTP vaccine
appears to have a negative effect, particularly in females.
Immunization visits are scheduled for 6 10 and 14 wks of age when DTP vaccine
and OPV are administered.
"About 10 million children still do not receive the third dose of DTP vaccine
in the Region.